Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04072211
PHASE4

Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District

Sponsor: Centre for Infectious Disease Research in Zambia

View on ClinicalTrials.gov

Summary

Hepatitis B virus (HBV) has infected over one third of the world's population; of these about 350 million go on to be chronic carriers. Infection with HBV can be self-limiting depending on age and immunity status of the infected person. Acute infection with HBV is cleared within six months of initial infection while chronic infection can last longer than six months. HBV can be transmitted perinatally, sexually, horizontally, through direct contact with infectious body fluids or blood, being pricked with an infected needle and injury from instruments contaminated with infectious body fluid or blood. Certain population groups are at higher risk of infection with HBV. Among these populations is that of health care workers (HCWs). In this population, HBV infection can occur through occupational exposure. In fact, the hepatitis B virus is more contagious than human immunodeficiency virus (HIV) during a needle stick injury (30% versus 0.5%). It is therefore imperative that HCWs are highly knowledgeable about HBV and how they can prevent transmission. Protection from HBV infection can be achieved by means of vaccination after which the HBV vaccine has been shown to be 90-100% effective.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

641

Start Date

2019-11-25

Completion Date

2020-08-30

Last Updated

2026-08-10

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

Engerix-B

Hepatitis B vaccine administered through intramuscular injection at 0, 1, and 6 months

Locations (1)

Kalulushi district all facilities

Kalulushi, Copperbelt, Zambia